Free Trial

Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Grows By 125.9%

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden Corporation experienced a significant increase in short interest of 125.9% in August, rising from 2,700 to 6,100 shares.
  • The company reported last quarterly earnings on August 6, with an EPS of $0.01 and revenue of $346.24 million.
  • Nihon Kohden's stock is currently trading at $11.62, with a market cap of $1.99 billion and a fifty-two week range between $9.86 and $17.28.
  • Five stocks we like better than Nihon Kohden.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 6,100 shares, an increase of 125.9% from the August 15th total of 2,700 shares. Based on an average trading volume of 10,800 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 10,800 shares, the days-to-cover ratio is currently 0.6 days.

Nihon Kohden Stock Down 1.4%

OTCMKTS:NHNKY traded down $0.17 during mid-day trading on Thursday, reaching $11.82. 3,257 shares of the company were exchanged, compared to its average volume of 6,792. Nihon Kohden has a 12 month low of $9.86 and a 12 month high of $17.28. The company has a fifty day moving average of $11.67 and a 200 day moving average of $12.41. The stock has a market cap of $2.02 billion, a PE ratio of 21.89 and a beta of 0.40.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. Nihon Kohden had a net margin of 5.77% and a return on equity of 6.74%. The firm had revenue of $346.24 million for the quarter.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

See Also

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.